drugset / Trial / NCT06436781
Effect of Maolactin™ FMR on Exercise Recovery, Inflammation, and Muscle Comfort in an Otherwise Healthy Population
RandomizedParallel-groupDouble-blindTreatment
Summary
This is a double blind, randomised, placebo-controlled, parallel-group trial to evaluate the effect of Maolactin FMR supplementation on post exercise inflammation, exercise recovery and muscle fatigue and pain in an otherwise healthy population of adults 18-65 years old over 10 weeks with 8 weeks of supplementation. This is PART A of the study.
Timeline
- Start
- 2024-09-12
- Primary completion
- 2025-05-23
- Completion
- 2025-05-23
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Maolactin | Protein / enzyme biologic | 500 mg | — |